You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mRNA-1273 vaccine

Showing 1 - 25 of 8,833
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy, Chronic Stable Illness Trial in United States (casirivimab+imdevimab, Moderna mRNA-1273 vaccine)

Completed
  • Healthy
  • Chronic Stable Illness
  • Little Rock, Arkansas
  • +5 more
Jan 9, 2023

COVID-19 Immunogenicity ofThird Dose of mRNA-1273 Vaccine Among

Active, not recruiting
  • Covid19
  • SARS-CoV2 Infection
  • mRNA-1273
  • Tampa, Florida
    Moffitt Cancer Center
Jun 20, 2022

SARS-CoV-2 mRNA-1273 Vaccine in Select Subsets of Oncology

Active, not recruiting
  • Covid19
  • Cancer
  • Blood Sample
  • Rochester, New York
    University of Rochester
Sep 6, 2022

COVID-19 Pandemic, Immunogenicity, SARS CoV 2 Infection Trial in Ramat-Gan (mRNA-1273.214 Vaccine, MRNA-1273 Vaccine, Placebo)

Recruiting
  • COVID-19 Pandemic
  • +3 more
  • mRNA-1273.214 Vaccine
  • +2 more
  • Ramat-Gan, Israel
    Sheba Medical Center
Oct 26, 2022

Compare mRNA-1273 Versus BNT162b2 COVID-19 Vaccines Among

Completed
  • SARS-CoV-2
    • New York, New York
      Aetion Inc.
    May 5, 2022

    COVID-19 Pandemic Trial in Ramat-Gan (mRNA1273 vaccine)

    Active, not recruiting
    • COVID-19 Pandemic
    • mRNA1273 vaccine
    • Ramat-Gan, Israel
      Sheba Medical Center
    Feb 8, 2022

    SARS-CoV-2, Influenza Trial in United States (mRNA-1073, mRNA-1010, mRNA-1273)

    Active, not recruiting
    • SARS-CoV-2
    • Influenza
    • mRNA-1073
    • +3 more
    • Hollywood, Florida
    • +13 more
    Oct 5, 2022

    SARS-CoV-2 Trial in Atlanta, Seattle (mRNA-1273)

    Active, not recruiting
    • SARS-CoV-2
    • mRNA-1273
    • Mesa, Arizona
    • +14 more
    Aug 31, 2022

    Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)

    Recruiting
    • Solid Tumor Malignancy
    • +4 more
    • mRNA-1273
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 14, 2023

    COVID-19, COVID-19 Immunisation Trial in Decatur, Bethesda, Seattle (mRNA-1273)

    Completed
    • COVID-19
    • COVID-19 Immunisation
    • mRNA-1273
    • Decatur, Georgia
    • +2 more
    Jan 26, 2023

    Vaccine Response Impaired, Immune Suppression, Covid19 Trial in Toronto (mRNA-1273 vaccine, Normal Saline Placebo)

    Completed
    • Vaccine Response Impaired
    • +2 more
    • mRNA-1273 vaccine
    • Normal Saline Placebo
    • Toronto, Ontario, Canada
    • +1 more
    Jul 29, 2022

    Lung Transplant Recipient, SARS-CoV-2, Immunosuppression Trial (mRNA-1273 (Moderna COVID-19 vaccine))

    Active, not recruiting
    • Lung Transplant Recipient
    • +2 more
    • mRNA-1273 (Moderna COVID-19 vaccine)
    • Los Angeles, California
      UCLA Clinical Translational Research Center
    Dec 13, 2022

    SARS-CoV-2 Trial in United States (mRNA-1273.211, mRNA-1273, mRNA-1273.617.2)

    Active, not recruiting
    • SARS-CoV-2
    • mRNA-1273.211
    • +6 more
    • Sacramento, California
    • +22 more
    Nov 16, 2022

    SARS-CoV-2 Trial in United States (mRNA-1283, mRNA-1273, Placebo)

    Active, not recruiting
    • SARS-CoV-2
    • mRNA-1283
    • +2 more
    • Chandler, Arizona
    • +4 more
    Sep 22, 2022

    COVID-19, COVID-19 Immunisation Trial in United States (mRNA-1273, mRNA-1273.351)

    Active, not recruiting
    • COVID-19
    • COVID-19 Immunisation
    • mRNA-1273
    • mRNA-1273.351
    • Decatur, Georgia
    • +3 more
    Aug 11, 2022

    Covid19 Trial (MRNA-1273)

    Not yet recruiting
    • Covid19
    • (no location specified)
    Jun 17, 2021

    Severe Exacerbation of Severe Acute Respiratory Syndrome

    Active, not recruiting
    • SARS-CoV-2
      • Tokyo, Japan
        CMIC Co. Ltd.,
      Jun 5, 2023

      Japan After Severe Acute Respiratory Syndrome Coronavirus 2

      Not yet recruiting
      • SARS-CoV-2
        • Tokyo, Japan
          CMIC Co., Ltd
        Jun 6, 2023

        Healthy Adult Volunteers Trial in Taipei City (ChAdOx1-nCov-19 (Astra-Zeneca), SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine)

        Completed
        • Healthy Adult Volunteers
        • ChAdOx1-nCov-19 (Astra-Zeneca)
        • SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine
        • Taipei City, X, Taiwan
          National Taiwan University Hospital
        Oct 16, 2022

        Kidney Transplant Recipients Trial in Baltimore (mRNA-1273 vaccine (Pfizer/BioNTech), mRNA-1273 vaccine (Moderna))

        Active, not recruiting
        • Kidney Transplant Recipients
        • mRNA-1273 vaccine (Pfizer/BioNTech)
        • mRNA-1273 vaccine (Moderna)
        • Baltimore, Maryland
          Johns Hopkins Hospital
        Oct 4, 2021

        Risk Factors of Myocarditis and Pericarditis After Moderna

        Active, not recruiting
        • Myocarditis, Pericarditis
        • mRNA-1273
        • Aarhus, Denmark
        • +4 more
        Oct 31, 2023

        COVID-19, Breakthrough Infection Trial in Taoyuan city (BNT162b2, mRNA-1273, MVC-COV1901)

        Active, not recruiting
        • COVID-19
        • Breakthrough Infection
        • BNT162b2
        • +2 more
        • Taoyuan city, Taiwan
          Chang Gung Memorial Hospital
        Jul 21, 2022

        A Study of the Effectiveness of Moderna COVID-19 Vaccine

        Recruiting
        • SARS-CoV-2
        • COVID-19
        • mRNA-1273
        • Pasadena, California
          Kaiser Permanente Southern California
        Jul 5, 2023

        SARS-CoV-2 Trial in United States (mRNA-1273.214)

        Recruiting
        • SARS-CoV-2
        • mRNA-1273.214
        • Montebello, California
        • +6 more
        Jul 28, 2022

        Vaccination; Infection, COVID-19 Trial in Leiden (solid microneedle skin patch, mRNA-1273, standard needle)

        Recruiting
        • Vaccination; Infection
        • COVID-19
        • solid microneedle skin patch
        • +2 more
        • Leiden, Netherlands
          Leiden University Medical Center
        Apr 14, 2022